CCL Loses Its Fizz After Yesterday’s AGM

Shares of CCL are down 4% to $8.60 in early trade as yesterday’s AGM offered little definitive forward guidance about growth and earnings.

Investors were looking for an update on operational margins not only in Australia but in the ventures in PNG, ANZ and Indonesia.

There was no change to the planned 21 cent dividend for August 28th, and we see initial support for CCL in the $8.50 area.

Coca Cola

 

 

Buy Medibank & sell covered call options

Our Algo Engine recently generated a buy signal in Medibank at $2.80.

With the stock now making a further “higher low” formation at $3.00, we recommend buying MPL and selling December call options to enhance the yield.

December $3.20 call options are generating an additional $0.08 in premium.

Medibank goes ex-div $0.0675 on the 6th September

Medibank Private

 

A2M Drops 15% on Weaker Full-Year Guidance

Shares of A2 milk have opened over 15% lower to $9.80 after reporting lower guidance in their trading update and full year outlook.

The company reported that they expected total revenue near the NZ 920 million mark. This materially below the NZ 950 million the company was shooting for earlier this year.

Technically, we see scope for A2M shares to fill the price gap from February and find support near $9.00.

A2 Milk